Adejoro IA, Babatunde DD, Tolufashe GF. 2020. Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: an
in silico study. Journal of Taibah University for Science 14 (1): 1563-1570. DOI:
https://doi.org/10.1080/16583655.2020.1848049.
Afrisham R, Aberomand M, Ghaffari MA, Siahpoosh A, Jamalan M. 2015. Inhibitory effect of
Heracleum persicum and
Ziziphus jujuba on activity of alpha-amylase. Journal of Botany. DOI:
https://doi.org/10.1155/2015/824683.
Afsharmanesh MR, Mohammadi Z, Jafari SM. 2024. Iranian medicinal plants in diabetes management: a narrative review of traditional herbal remedies and their hypoglycemic effects. Journal of Food Biochemistry 2024 (1): 6694085. DOI:
https://doi.org/10.1155/jfbc/6694085.
Alam F, Islam MA, Kamal MA, Gan SH. 2018. Updates on managing type 2 diabetes mellitus with natural products: towards antidiabetic drug development. Current Medicinal Chemistry 25 (39): 5395-5431. DOI:
https://doi.org/10.2174/0929867323666160813222436.
Alizadeh Z, Fattahi M, Farokhzad A, Asghari B, Yousefzadeh-Valendeh S, Alipour H, Palazon J. 2025. Green nanoparticles synthesized from damask rose petals: Evaluation of their antioxidant, antimicrobial, anti-diabetic, anti-Alzheimer, and photocatalytic properties. Heliyon, 11 (4): e42557. DOI:
https://doi.org/10.1016/j.heliyon.2025.e42557.
Association AD. 2018. 2. Classification and diagnosis of diabetes:
standards of medical care in diabetes—2018. Diabetes Care, 41 (Supplement_1): S13-S27. DOI:
https://doi.org/10.2337/dc18-S002.
Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D’Alessio DA, Davies MJ. 2020. 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43 (2): 487-493. DOI:
https://doi.org/10.2337/dci19-0066.
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. 2003. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (1): 102-110. DOI:
https://doi.org/10.2337/diabetes.52.1.102.
Chakrabarti R, Rajagopalan R. 2002. Diabetes and insulin resistance associated disorders: disease and the therapy. Current Science Association 83 (12): 1533-1538.
Cho NH, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, Malanda B. 2018. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice 138: 271-281. DOI:
https://doi.org/10.1016/j.diabres.2018.02.023.
Cnop M, Welsh N, Jonas J-C, Jorns A, Lenzen S, Eizirik DL. 2005. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (suppl_2): S97-S107. DOI:
https://doi.org/10.2337/diabetes.54.suppl_2.s97.
Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. 2020. Pharmacologic approaches to glycemic treatment of type 2 diabetes: synopsis of the 2020 American diabetes association's standards of medical care in diabetes clinical guideline. Annals of Internal Medicine, 173 (10): 813-821. DOI:
https://doi.org/10.7326/m20-2470.
Eden Miller D, Aguilar RB, Schwartz SS. 2019. Type 2 diabetes: evolving concepts and treatment. Cleveland Clinic Journal of Medicine 86 (7): 494-504. DOI:
https://doi.org/10.3949/ccjm.86a.17107.
Fu Z, Gilbert ER, Liu D. 2013. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Current Diabetes Reviews 9 (1): 25-53.
Gheissari A, Hemmatzadeh S, Merrikhi A, Tehrani SF, Madihi Y. 2012. Chronic kidney disease in children: A report from a tertiary care center over 11 years. Journal of Nephropathology 1 (3): 177-182. DOI:
https://doi.org/10.5812/nephropathol.8119.
Ghosal S, Arora B, Dutta K, Ghosh A, Sinha B, Misra A. 2020. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: a cohort analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (5): 949-952. DOI:
https://doi.org/10.1016/j.dsx.2020.06.020.
Greiner EF, Guppy M, Brand K. 1994. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. Journal of Biological Chemistry 269 (50): 31484-31490. DOI:
https://doi.org/10.1016/S0021-9258(18)31720-4.
Kalra S. 2014. Alpha glucosidase inhibitors. JPMA: The Journal of the Pakistan Medical Association 64 (4): 474-476.
Kooti W, Moradi M, Ali-Akbari S, Sharafi-Ahvazi N, Asadi-Samani M, Ashtary-Larky D. 2015. Therapeutic and pharmacological potential of Foeniculum vulgare Mill: a review. Journal of HerbMed Pharmacology 4 (1): 1-9.
Lagunin AA, Goel RK, Gawande DY, Pahwa P, Gloriozova TA, Dmitriev AV, Ivanov SM, Rudik AV, Konova VI, Pogodin PV. 2014. Chemo-and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review. Natural Product Reports 31 (11): 1585-1611. DOI:
https://doi.org/10.1039/c4np00068d.
Laskowski RA, Swindells MB. 2011. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling 51 (10): 2778-2786. DOI:
https://doi.org/10.1021/ci200227u.
Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE. 2011. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 60 (1): 1-23. DOI:
https://doi.org/10.1016/j.metabol.2010.09.010.
Organization WH. 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization.
https://iris.who.int/handle/10665/43588.
Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. 2020. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The Aging Male 23 (5): 1416-1424. DOI:
https://doi.org/10.1080/13685538.2020.1774748.
Poovitha S, Parani M. 2016. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (
Momordica charantia L.). BMC Complementary and Alternative Medicine 16 Suppl 1 (Suppl 1): 185. DOI:
https://doi.org/10.1186/s12906-016-1085-1.
Read PA, Khan FZ, Heck PM, Hoole SP, Dutka DP. 2010. DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease. Circulation: Cardiovascular Imaging 3 (2): 195-201. DOI:
https://doi.org/10.1161/circimaging.109.899377.
Ren L, Qin X, Cao X, Wang L, Bai F, Bai G, Shen Y. 2011. Structural insight into substrate specificity of human intestinal maltase-glucoamylase. Protein Cell 2 (10): 827-836. DOI:
https://doi.org/10.1007/s13238-011-1105-3.
Rolta R, Salaria D, Kumar V, Patel CN, Sourirajan A, Baumler DJ, Dev K. 2022. Molecular docking studies of phytocompounds of
Rheum emodi Wall with proteins responsible for antibiotic resistance in bacterial and fungal pathogens:
in silico approach to enhance the bio-availability of antibiotics. Journal of Biomolecular Structure and Dynamics 40 (8): 3789-3803. DOI:
https://doi.org/10.1080/07391102.2020.1850364.
Rudenski A, Hadden D, Atkinson A, Kennedy L, Matthews D, Merrett J, Pockaj B, Turner R. 1988. Natural history of pancreatic islet B‐cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabetic Medicine 5 (1): 36-41. DOI:
https://doi.org/10.1111/j.1464-5491.1988.tb00938.x.
Rudnitskaya A, Török B, Török M. 2010. Molecular docking of enzyme inhibitors: A Computational tool for structure-based drug design. Biochemistry and Molecular Biology Education 38 (4): 261-265. DOI:
https://doi.org/10.1002/bmb.20392.
Saad B, Said O. 2011. Greco-Arab and Islamic herbal medicine: traditional system, ethics, safety, efficacy, and regulatory issues. John Wiley & Sons. DOI:
http://doi.org/10.1002/9780470944363.
Salehi B, Ata A, V Anil Kumar N, Sharopov F, Ramirez-Alarcon K, Ruiz-Ortega A, Abdulmajid Ayatollahi S, Valere Tsouh Fokou P, Kobarfard F, Amiruddin Zakaria Z. 2019. Antidiabetic potential of medicinal plants and their active components. Biomolecules 9 (10): 551. DOI:
https://doi.org/10.3390/biom9100551.
Scheen AJ, Paquot N. 2013. Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism 39 (3): 179-190. DOI:
https://doi.org/10.1016/j.diabet.2013.02.006.
Sharma R, Arya V. 2011. A review on fruits having anti-diabetic potential. Journal of Chemical and Pharmaceutical Research 3 (2): 204-212.
Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry 31 (2): 455-461. DOI:
https://doi.org/10.1002/jcc.21334.
Williams LK, Zhang X, Caner S, Tysoe C, Nguyen NT, Wicki J, Williams DE, Coleman J, McNeill JH, Yuen V, Andersen RJ, Withers SG, Brayer GD. 2015. The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif. Nature Chemical Biology 11 (9): 691-696. DOI:
https://doi.org/10.1038/nchembio.1865.
Van de Laar F, Lucassen P, Akkermans R, Van de Lisdonk E, Rutten G, Van Weel C. 2005. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. DOI:
https://doi.org/10.1002/14651858.CD003639.pub2.
Yousefzadeh-Valendeh S, Fattahi M, Asghari B, Alizadeh Z. 2023. Dandelion flower-fabricated Ag nanoparticles versus synthetic ones with characterization and determination of photocatalytic, antioxidant, antibacterial, and α-glucosidase inhibitory activities. Scientific Reports 13: 15444. DOI:
https://doi.org/10.1038/s41598-023-42756-0.
Zhang Y, Ma ZF. 2020. Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: A cross-sectional study. International Journal of Environmental Research and Public Health 17 (7): 2381. DOI:
https://doi.org/10.3390/ijerph17072381.
)